AllDocs -> cancers

prostate cancer The PCNG or Prostate Cancer Networking Group is a support group for prostate cancer patients in Greater Cincinnati we meet twice a month: the second Wednesday of the month (small group of patients and a small group of care givers) and the last Wednesday (men and women, with a speaker, often a MD) NEXT SMALL GROUP MEETING WILL BE HELD ON MAY 8th, 7 pm: Please, come!! NEXT LARGE GROUP MEETING WILL BE HELD ON MAY 29th, 7 pm: Please, come!! 7-8: new members and networking; talk at 8: Prof. Peter Stambrook & Dr. Karen Knudsen: ?News from the 2002 AACR meeting? the AACR is the American Association of Cancer Research - their annual meeting was in San Francisco April 6-10, 2002. Dr. Stambrook is chair of the Department of Cell Biology, Neurobiology & Anatomy, UC Dr. Karen Knudsen in his department is specialized in prostate ...

Prostate Cancer Profile : For the State of Nevada PDF NAVIGATION INSTRUCTIONS Click on BOOKMARKS to see a list of the pages contained in this file. Use the navigation buttons at the top or bottom of your screen to navigate through the site. Use the navigation back button at the top or bottom of your screen to go back to the first page in the file. Use the navigation end button at the top or bottom of your screen to go to the last page in this file. Use the navigation last and forward buttons at the top or bottom of your screen to go to the last page or the next page in this file. Use the magnifying glass at the top of your screen to zoom in on a page. DoIT Web Development Team LMDeSantis, March 2004 Page 2 Prostate Cancer ...

Scientific summary Prostate cancer care: improving measures of the patient experience Lead researcher: Professor Richard Baker, University of Leicester Aim To develop valid, reliable and usable measures of patient experience of prostate cancer care suitable for use in routine practice. Design 1. Interview and questionnaire survey of CSCs to establish their requirements for the measure(s) 2. Review of literature on patients’ experiences of prostate cancer care 3. Qualitative study of patients’ experiences of prostate cancer care 4. Development of a new measure from the NCPS questionnaire 5. Consensus study of the completeness of the new measure(s) 6. Question reduction through sequential pilots and elimination of redundant questions 7. Submission of the draft measure(s) to a sample of 400 patients of four CSCs to assess reliability, validity ...

C a n c e r C o n t r o l Editorial November/December 2001, Vol.8, No.6 480 Cancer Control The dawn of the 21st century witnessed momentous advances in our understanding of prostate can- cer: refinements in molecular and cell biology technology, better diagnostic and staging methods, improvements in local treatments, and the discovery of more effec- tive chemotherapies, just to men- tion a few. Still, there is much to learn about this common disease. We lack knowledge of the funda- mental mechanisms leading to the initiation, promotion, and progres- sion of this cancer . We have multi- ple choices, but we still do not know what is the best treatment for localized disease, and a signifi- cant percentage of patients who undergo treatment for early dis- ease progress to advanced ...

• Prostate cancer is the most common cancer among American men. • Men who are older than 50 years of age, are African American, or have a brother or father with prostate cancer are more likely than other men to get prostate cancer . • In some men prostate cancer grows very slowly, and in other men it spreads quickly. • If you are at risk, talk with your doctor about the risks and benefits of tests such as a rectal exam and prostate -specific antigen (PSA) to find prostate cancer . Sample Prevention Prescriptions for Adults 181 Name: __ R X for Prevention Follow-up: _ __ __ __ Clinician’s Signature: Date: Put Prevention Into Practice Prostate Cancer

PROSTATE CANCER : Surgery and radiation cause different complications. Researchers led by a team from the National Cancer Institute compared the side effects of treatments for localized prostate cancer in 1,591 men between the ages of 55 and 74. Two years after treatment, the 1,156 men who had surgery had more problems with urinary incontinence (9.6 percent vs. 3.5 percent) and impotence (79.6 percent vs. 61.5 percent) compared to those who had radiation. The 435 men who had radiation had more bowel problems such as diarrhea (37.2 percent vs. 20.9 percent). Ninety-two percent of all patients said they would choose the same treatment again. This is the first study to directly compare side effects of radiation vs. surgery for the treatment of localized prostate cancer in a diverse group of patients. The men were surveyed about side effects at six, 12 and 24 months after diagnosis. The characteristics ...

1 Town Hall Meetings Comments and Suggestions Prostate Cancer Comments • Native American community cancers include prostate cancer . • Prostate cancer is a problem. There is screening but no money for follow up. • Prostate screenings are being funded through the tobacco settlement funding and are not connect to what a person may owe the system. No one should be refused as long as the money is there. • Johns Hopkins Hospital will not do a screen for prostate cancer if person owes money to their system. • There are eligibility criteria but because of the high rate of prostate cancer in African American men, we will screen any African American man over 45. If they have no insurance, there is no cost. If they have insurance, the funding pays for what ever the insurance does not pay. Basically it is free ...

Action Plan on Prostate Cancer for the State of Texas Developed by: Texas Medical Association’s Physician Oncology Education Program Andrew Miller, MHSE, CHES Project Director Robin C. Calloway Project Coordinator Debbie Celusniak Graphic Artist This project is a collaboration of these agencies and organizations: American Cancer Society, Texas Division, Inc. Texas Cancer Council Texas Department of Health Texas Medical Association Funded by the Centers for Disease Control and Prevention, under grant number U55-CCU616039 This report is also available on the Web at: www.tcc.state.tx.us FEBRUARY 2002 TEXAS CANCER COUNCIL Page 2 Page 3 CONTENTS I iii Contents Introduction v ...

HUMAN PROSTATE CANCER CELLS LACK FEEDBACK REGULATION OF LOW-DENSITY LIPOPROTEIN RECEPTOR AND ITS REGULATOR, SREBP2 Yunfei C HEN and Millie H UGHES -F ULFORD * Laboratory of Cell Growth, University of California San Francisco and Veterans Affairs Medical Center, San Francisco, CA, USA The low-density lipoprotein receptor (LDLR) pathway pro- vides cells with essential fatty acids for prostaglandin E 2 (PGE 2 ) synthesis. Regulation of LDLR expression by LDL was compared between the human normal and cancer prostate cells using semi-quantitative RT-PCR and LDL uptake assays. LDLR mRNA expression and LDL uptake by LDLR were down-regulated in the presence of exogenous LDL or whole serum in the normal prostate cells, but not in the prostate cancer cells. Addition of exogenous cholesterol ...

Sponsored by E DUCATION & S UPPORT P ROGRAM and C ANCER Palouse P ROSTATE PROGRAM GOALS 1. Assist men with difficult treatment decisions. 2. Provide an educational resource on prostate cancer . 3. Assist men coping with prostate cancer 4. Providing a support group for partners of men with prostate cancer . 5. Participating in community education programs to help prevent prostate cancer and achieve early diagnosis. MEETING TIMES The Prostate Cancer Support Group meets the first Tuesday of each month from 7:30 to 9:30 pm. FOR MORE INFORMATION Please call: Bruce Palmer at 509-332-5683 Email: brucepal@gte.net ...

UAMS UPDATE September 1999 University of Arkansas for Medical Sciences (501) 686-6271 . . . UAMS Medical Center To Offer Free Prostate Cancer Screenings Greene I n the past, if someone mentioned being screened for prostate cancer , Frank Milat’s response was the same as a lot of men: “What I don’t know can’t hurt me.” After undergoing a free screening at UAMS Medical Center last September, Milat knows differently. From the results of his screening, he became one of more than 209,000 American men who were diagnosed with prostate cancer in 1998. Under the care of UAMS Medical Center urologist Graham Greene, M.D., Milat has received successful treatment over the past several months. However, he never forgets the importance of that initial screening. In a continuing effort to increase prostate cancer awareness, ...

INAHTA Joint Project Prostate Cancer Screening Evidence Synthesis and Update Statements of Findings Tore Schersten * , M. Angeles Baile # José Asua # , Egon Jonsson * * The Swedish Council on Technology Assessment in Health Care (SBU). Sweden # Basque Office for Health Technology Assessment. (OSTEBA). Deparment of Health Basque Goverment. Spain January 1999 Page 2 Prostate Cancer Screening . Evidence Synthesis and Update. Statement of findings 2 INAHTA Joint Project Copyright Basque Office for Health Technology Assessment, Osteba. Dpt. of Health Basque Goverment. 1999 Published in name of the Network the International of Agencies of Evaluation of Tecnologías Sanitarias (INAHTA) by: Basque Office for Health Technology ...

APPENDIX H Current Research Efforts To Resolve the Effectiveness of Prostate Cancer Screening and Treatment ost evidence-based criteria for evaluat- ing screening maneuvers demand evi- dence from controlled studies on which to base recommendations. Randomized controlled trials (RCTs) are the best studies on which to base such recommendations. In the absence of RCTs, researchers and policymakers often examine less desirable cohort studies with concurrent nonrandomized controls and case-control studies. Un- fortunately, in the area of early detection and treatment of prostate cancer , little controlled data are available, re- gardless of study design. A single case-control study has shown no evidence of benefit from digital rectal ex- amination (DRE), in terms of lower exposure odds to DRE within the prior 10-year period among men with metastatic prostate ...

C onseil d’ É valuation des T echnologies de la S anté du Québec Report submitted to the Minister of Research, Science and Technology of Québec Conseil d’évaluation des technologies de la santé du Québec Report – January 2000 BRACHYTHERAPY AND PROSTATE CANCER (CETS 99-5 RE) Page 2 Information concerning this report or any other report published by the Conseil d'évaluation des technologies de la santé can be obtained by contacting the Conseil : Conseil d’évaluation des technologies de la santé 201, boulevard Crémazie est, Bureau 1.03 Montréal (Québec) H2M 1L2 Telephone: (514) 873-2563 Fax: (514) 873-1369 E-mail: cets@msss.gouv.qc.ca Web site address: http://www.msss.gouv.qc.ca/cets/ Legal deposit Bibliothèque nationale du Québec, ...

MDACC Suspicion of Prostate Cancer Positive screening exam or Urinary obstructive symptoms DRE PSA >4 ng/ml? TRUS Treat other causes of symptoms Annual DRE and PSA TRUS-guided biopsy (Sextant biopsies if no lesion on TRUS) TRUS-guided biopsy TRUS-guided biopsy DRE and PSA in 6-12 months Positive Positive for nodule Neg (V1;10/26/98;5/21/99) Neg No Yes TRUS-guided biopsy negative Refer to Prostate Cancer Practice Guideline Low grade: continue follow-up with urologist (annual DRE and PSA). High grade: repeat PSA and biopsy in 1-4 months. TRUS-guided biopsy positive for PIN TRUS-guided biopsy positive for cancer Screening: Annual DRE and PSA for men aged 50-70 yr (Begin at age 40 for African-American men and those with a ...

The Global Structure of Prostate Cancer R&D September 2003 © BioSeeker Group www.bioseeker.com Page 2 BioSeeker Group AB BSG Basic Platform Report The Global Structure of Prostate Cancer R&D © BioSeeker Group September 2003 2 EXECUTIVE SUMMARY In Europe and the US there are close to 20 million people that live with cancer today, a figure that is increasing. 6.2 million people worldwide died of cancer in 1998. The American Cancer Society estimates that approximately 1.2 million new cancer cases were diagnosed in the year 2000 in the US. Overall annual costs associated with cancer currently amount to $107 billion in the United States alone. The worldwide anti- cancer market was valued at more than $15 billion in 1998 and is projected to nearly double by 2003. Approximately 30% of all ...

MAN TO MAN & SIDE BY SIDE ( Prostate Cancer Support Groups) Invite you to a Special Prostate Cancer Awareness Night at the Toronto Botanical Garden – Floral Hall Room (Formerly Civic Garden Centre) at Edwards Gardens Lawrence Avenue at Leslie (southwest corner) FREE parking! on Wednesday July 28, 2004 at 7:30 p.m. featuring Man To Man Prostate Cancer Survivors in a unique “Survivors’ Forum” Hear when and how other men were diagnosed with prostate cancer . Find out how and why they decided on their own particular treatment choices - whether surgery (Radical Prostatectomy), External Beam Radiation Therapy or Brachytherapy. Acquire more information about the choices available to you. Hear how one woman dealt with her husband’s diagnosis. ...